INR 53.6
(2.85%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -10.9 Million | -31.89 Million | 55.18 Million | 26.03 Million | 68.42 Million | -51.71 Million |
Net Income | -118.78 Million | -166.29 Million | -298.39 Million | -175.16 Million | -14.71 Million | 50.98 Million |
Depreciation & Amortization | 27.47 Million | 18.77 Million | 13.65 Million | 15.9 Million | 20.1 Million | 18.85 Million |
Deferred income taxes | - | - | - | - | 356 Thousand | - |
Stock-based compensation | - | - | - | - | - | 6.69 Million |
Change in working capital | 81.99 Million | 226.89 Million | 344.52 Million | 190.67 Million | 29.33 Million | -148.92 Million |
Other non-cash items | 108.09 Million | -111.27 Million | -4.6 Million | -5.37 Million | 43.2 Million | 27.37 Million |
Investing Cash Flow | 5.55 Million | 129.94 Million | -12.36 Million | -6.38 Million | -15.98 Million | 1.28 Million |
Investments in PPE | 10.9 Million | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -221 Thousand | -83.96 Million | -13.77 Million | -5.86 Million | -14.14 Million | -5.3 Million |
Sales/Maturities of investments | 30 Thousand | 150.13 Million | - | - | 27 Thousand | 927 Thousand |
Other Investing Activities | 5.75 Million | 63.77 Million | 1.41 Million | -520 Thousand | -1.86 Million | 5.66 Million |
Financing Cash Flow | 5.12 Million | -101.3 Million | -41.34 Million | -22.76 Million | -51.2 Million | 51.47 Million |
Debt repayment | -38.38 Million | -402.11 Million | -4.02 Million | -24.74 Million | -46.16 Million | -2.67 Million |
Dividends payments | - | - | - | - | -1.42 Million | -1.06 Million |
Common Stock Repurchased | - | - | - | - | -42.83 Million | - |
Common Stock Issuance | - | 264.29 Million | 7.9 Million | - | 43.11 Million | 2.18 Million |
Other Financing Activities | -33.25 Million | 36.51 Million | -45.21 Million | 1.98 Million | -4.14 Million | 49.87 Million |
Accounts receivables | 57.26 Million | 67.61 Million | 10.58 Million | 103.51 Million | 43.75 Million | -187.34 Million |
Accounts payables | -132.72 Million | 5.03 Million | 88.36 Million | -14.68 Million | 55.56 Million | 13.87 Million |
Inventory | 20.71 Million | 153.97 Million | 129.05 Million | 20.6 Million | -63.26 Million | 20.04 Million |
Other working capital | 136.74 Million | 273 Thousand | 116.51 Million | 81.24 Million | -6.72 Million | 4.49 Million |
Cash at beginning of period | 2.05 Million | 5.31 Million | 3.83 Million | 6.94 Million | 5.71 Million | 4.66 Million |
Cash at end of period | 1.82 Million | 2.05 Million | 5.31 Million | 3.83 Million | 6.94 Million | 5.71 Million |
Capital Expenditure | 10.9 Million | - | - | - | - | - |
Effect of forex changes on cash | - | - | -1000.00 | 1000.00 | - | - |
Net cash flow / Change in cash | -230 Thousand | -3.25 Million | 1.47 Million | -3.11 Million | 1.23 Million | 1.04 Million |
Free Cash Flow | - | -31.89 Million | 55.18 Million | 26.03 Million | 68.42 Million | -51.71 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -43.88 Million | -118.78 Million | -20.14 Million | -40.14 Million | -14.61 Million | -166.29 Million |
Depreciation & Amortization | - | 27.47 Million | 6.83 Million | 6.92 Million | 6.96 Million | 18.77 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 81.99 Million | - | - | - | 226.89 Million |
Other non-cash items | 43.88 Million | 108.09 Million | 20.14 Million | 40.14 Million | 14.61 Million | -111.27 Million |
Investing Cash Flow | - | 5.55 Million | - | - | - | 129.94 Million |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -221 Thousand | - | - | - | -83.96 Million |
Sales/Maturities of investments | - | 30 Thousand | - | - | - | 150.13 Million |
Other Investing Activities | - | 5.75 Million | - | - | - | 63.77 Million |
Financing Cash Flow | - | 5.12 Million | - | - | - | -101.3 Million |
Debt repayment | - | -38.38 Million | - | - | - | -402.11 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | 264.29 Million |
Other Financing Activities | - | -33.25 Million | - | - | - | 36.51 Million |
Accounts receivables | - | 57.26 Million | - | - | - | 67.61 Million |
Accounts payables | - | -132.72 Million | - | - | - | 5.03 Million |
Inventory | - | 20.71 Million | - | - | - | 153.97 Million |
Other working capital | - | 136.74 Million | - | - | - | 273 Thousand |
Cash at beginning of period | - | 2.05 Million | 5.61 Million | 45.75 Million | 2.05 Million | 5.31 Million |
Cash at end of period | - | 1.82 Million | 19.28 Million | 5.61 Million | -14.61 Million | 2.05 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -230 Thousand | 13.66 Million | -40.14 Million | -16.66 Million | -3.25 Million |
Free Cash Flow | - | -10.9 Million | 13.66 Million | -40.14 Million | -14.61 Million | -31.89 Million |
8244
SHO
BAIDFIN
BKD
BUJAW
MEDS